Allegra HEMPHILL, Plaintiff, v. JOHNSON & JOHNSON, Defendant.
Civil Action No. 12-279 (CKK).
United States District Court, District of Columbia.
Jan. 29, 2013.
48
COLLEEN KOLLAR-KOTELLY, District Judge.
SO ORDERED this 29th day of January, 2013.5
Allegra Hemphill, Washington, DC, pro se.
George Frank Pappas, Baltimore, MD, Jeffrey B. Elikan, Kelly Vanderzell Silverman, Covington & Burling, LLP, Washington, DC, for Defendant.
MEMORANDUM OPINION
COLLEEN KOLLAR-KOTELLY, District Judge.
For more than a decade, Plaintiff Allegra Hemphill has filed suit in federal courts seeking to hold various companies liable for purportedly infringing United States Patent No. 4,557,720 (the “‘720 Patent“). This case represents the Plaintiff‘s fifth complaint alleging infringement of the ‘720 patent, and the second against Defendants Johnson & Johnson. Presently before the Court is the Defendant’s [7] Motion to Dismiss Complaint Under
I. BACKGROUND
For purposes of the Defendant’s motion to dismiss, the Court presumes all well-pleaded factual allegations in the Complaint are true. Atherton v. D.C. Office of Mayor, 567 F.3d 672, 681 (D.C. Cir. 2009), cert. denied, 559 U.S. 1039, 130 S.Ct. 2064, 176 L.Ed.2d 418 (2010). The Plaintiff filed a patent application for a “vaginal applicator” on June 11, 1984, claiming a priority date of October 18, 1982. Compl., Ex. 1 (‘720 Patent) at 1. The United States Patent and Trademark Office issued the ‘720 Patent on December 10, 1985 with two independent claims describing a disposable vaginal swab, intended to be used for cleansing or treating the vaginal area. Id. at 1, 4-5. The USPTO confirmed the patentability of both claims following reexamination proceedings in 1999. Pl.’s Ex. 2 (1/26/1999 Reexamination Certificate) at 1-2.
The Plaintiff initially filed suit against Johnson & Johnson in United States District Court for the District of Maryland in 1999, alleging Johnson & Johnson’s Stayfree, Carefree, and Serenity sanitary napkins аnd adult incontinence products infringed claim 2 of the ‘720 Patent. Hemphill v. McNeil-PPC, Inc., 134 F.Supp.2d 719, 723 (D. Md. 2001) (Hemphill I). The Maryland District Court substituted McNeil-PPC as the proper defendant and granted summary judgmеnt of noninfringement in favor of the defendant. Id. at 721, 727-29. The Federal Circuit affirmed the district court’s claim construction and findings of non-infringement on appeal. Hemphill v. McNeil-PPC, Inc., 25 Fed.Appx. 915 (Fed. Cir. 2001). The Plaintiff subsequently filed three separate suits against Kimberly-Clark Corp. and Procter & Gamble Co. alleging infringement of the ‘720 patent, all of which resulted in judgments in favor of the defendants. See Hemphill v. Kimberly-Clark Corp., 605 F.Supp.2d 183, 186-87 (D.D.C. 2009); Hemphill v. Kimberly-Clark Corp., 530 F.Supp.2d 108, 110 (D.D.C. 2008), aff‘d 335 Fed.Appx. 964 (Fed. Cir. 2008); Hemphill v. Procter & Gamble Co., 258 F.Supp.2d 410, 413 (D. Md. 2003), aff‘d 85 Fed.Appx. 765 (Fed. Cir. 2004).
The Plaintiff filed the present Complaint on February 21, 2012, alleging Johnson & Johnson’s Stayfree and Carefree feminine care products directly infringe the ‘720 Patent, and that the Defendant induced infringement of the ‘720 Patent by a third party. See generally Cоmpl., ECF No. [1]. Johnson & Johnson now moves to the dismiss the Complaint as untimely and barred by res judicata.
II. LEGAL STANDARD
III. DISCUSSION
The Defendant argues the Complaint should be dismissed for two reasons: (1) Plaintiff‘s claims are precluded by the doctrine of res judicata; and (2) Plaintiff‘s claims are untimely. The Court finds that the Plaintiff‘s claims of direct and indirect infringement were not timely asserted. Therefore, the Court does not reach the Defendant’s res judicata argument.
Several sections of Title 35 of the United States Code in combination govern the availability of a remedy for Plaintiff‘s claim of infringement. Section 271, on which Plaintiff bases her claim of infringement, provides in relevant part:
(a) Except as otherwisе provided in this title, whoever without authority makes, uses, offers to sell, or sells any patented invention, within the United States or imports into the United States any patented invention during the term of the patent therefor, infringes the patent.
(b) Whoever actively induces infringement of a patent shall be liable as an infringer.
Section 154(c)(1) defines the term of the ‘720 Patent as the later of (1) seventeen years from the date the patent issued; or (2) twenty years from the earliest filing date of an application on which the patent’s priority date is based. In other words, the term of the ‘720 patent is thе later of (1) seventeen years from December 10, 1985—December 10, 2002; or (2) twenty years from October 18, 1982—October 18, 2002.
The Plaintiff implies in her Opposition that the reexamination certificate issued by the United States Patent and Trademark Office on January 26, 1999, somehow altered the term of ‘720 Patent. To the contrary, reexamination certificates do not alter the term of a patent, even if a new claim is added or an original claim is amended during reexamination. See
The final statutory provision relеvant to the Defendant’s motion is section 286, which states that “no recovery shall be had for any infringement committed more than six years prior tо the filing of the complaint.”
IV. CONCLUSION
For the foregoing reasons, the Court finds the Plaintiff‘s claims are untimely. The ‘720 patent expired on December 10, 2002. The Plaintiff can only recover for infringing conduct that took place (1) before the patent expired; and (2) within six years of the date the complaint was filed. The Plaintiff filed her Complaint on February 10, 2012. Because the patent expired more than six years prior to the filing of the Complaint, as a matter of law, the Plaintiff cannot recover for any purportedly infringing conduct. Accordingly, the Defendant’s [7] Motion to Dismiss Complaint Under Rule 12(b)(6) is GRANTED.
An appropriate Order accompanies this Memorandum Opinion.
